Experts highlight access challenges in South Africa's Lenacapavir HIV prevention rollout

South Africa's groundbreaking rollout of the twice-yearly Lenacapavir HIV prevention injection faces significant challenges. Experts warn that without addressing longstanding barriers to healthcare access, the promise of this innovative solution may not be fully realised.

Raccontata daiol.co.za